Back to Semaglutide research
semaglutide gip agonist review 2026-04-22 PubMed

Canadian Review Analyzes Cost-Effectiveness of Incretin Therapies for Diabetes and Obesity

Cost-Effectiveness of Incretin Therapies: A Canadian Lens on Diabetes, Obesity, and Emerging Indications.

Abstract

Cost-Effectiveness of Incretin Therapies: A Canadian Lens on Diabetes, Obesity, and Emerging Indications. Authors: Awadalla L, Iskander S, Chu C, Tadrous M Journal: Canadian journal of physiology and pharmacology (2026) DOI: 10.1139/cjpp-2…

semaglutide tirzepatide gip agonist glp 1 agonist
Source: pubmed:42013575 · Ingested 2026-04-22 · Digest: gemini-2.5-flash